Is Sarepta Therapeutics (SRPT) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 05/28/20
Pfizer's Data Release Shows That It Still Is Light-Years Behind Sarepta In DMDSeeking Alpha • 05/21/20
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/07/20
Sarepta Therapeutics Announces Research Agreement with U.S. Department of Defense to Evaluate Multiple Constructs From its Proprietary RNA Platform as Treatments for COVID-19GlobeNewsWire • 04/28/20
Sarepta Therapeutics (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 03/31/20
Sarepta Therapeutics (SRPT) Down 8% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/20
Sarepta Therapeutics Announces Third Year of Route 79, The Duchenne Scholarship ProgramGlobeNewsWire • 02/27/20
Sarepta Therapeutics, Inc. (SRPT) CEO Douglas Ingram on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/27/20
Sarepta Therapeutics, Inc. And Arrowhead Pharmaceuticals Now Top-Ranked Biotech Stock BuysSeeking Alpha • 02/01/20
Sarepta Therapeutics (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 01/31/20
Sarepta Snagged After FDA Sheds Light On Its Initial Drug RejectionInvestors Business Daily • 01/23/20
Are Options Traders Betting on a Big Move in Sarepta (SRPT) Stock?Zacks Investment Research • 01/20/20
Casimersen Is A Lead Catalyst For Sarepta Therapeutics As A Top 2020 Stock PickSeeking Alpha • 01/15/20
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of DirectorsGlobeNewsWire • 01/13/20
Red-Hot Biotech Stocks Brace For Key Meeting — Here's What To ExpectInvestors Business Daily • 01/09/20